|Application ||FC, WB|
|Calculated MW||H=63,64;M=63;Rat=63 KDa|
|Antigen Region||445-473 aa|
|Other Names||GPI; Glucose-6-phosphate isomerase; Autocrine motility factor; Neuroleukin; Phosphoglucose isomerase; Phosphohexose isomerase; Sperm antigen 36|
|Target/Specificity||This GPI antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 445-473 amino acids from the C-terminal region of human GPI.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||GPI Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Besides it's role as a glycolytic enzyme, mammalian GPI can function as a tumor-secreted cytokine and an angiogenic factor (AMF) that stimulates endothelial cell motility. GPI is also a neurotrophic factor (Neuroleukin) for spinal and sensory neurons.|
|Cellular Location||Cytoplasm. Secreted|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
GPI belongs to the GPI family whose members encode multifunctional phosphoglucose isomerase proteins involved in energy pathways. The protein encoded by this gene is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate and fructose-6-phosphate. The protein functions in different capacities inside and outside the cell. In the cytoplasm, the gene product is involved in glycolysis and gluconeogenesis, while outside the cell it functions as a neurotrophic factor for spinal and sensory neurons. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment.
Shih, W.L., et al. Cancer Lett. 290(2):223-237(2010)
Davila, S., et al. Genes Immun. 11(3):232-238(2010)
Araki, K., et al. J. Biol. Chem. 284(47):32305-32311(2009)
Tsutsumi, S., et al. Int. J. Oncol. 35(5):1117-1121(2009)
Funasaka, T., et al. Cancer Res. 69(13):5349-5356(2009)
Yanagawa, T., et al. J. Biol. Chem. 280(11):10419-10426(2005)
Haga, A., et al. Biochim. Biophys. Acta 1480 (1-2), 235-244 (2000)
If you have any additional inquiries please email technical services at email@example.com.